News
13h
MedPage Today on MSNMifepristone Helped Control Diabetes in Those With HypercortisolismCHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...
1d
MedPage Today on MSNOzempic Shows Benefit in Type 1 Diabetes Patients With Obesity"Nearly 62% of adults with type 1 diabetes are either overweight or obese, which is associated with insulin resistance, ...
2d
MedPage Today on MSNOnce-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 DiabetesA once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III ...
Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...
Want to lose weight and reverse type 2 diabetes? Trade diet soda for a tall glass of water, a new small-scale study argues.
Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June ...
In a rodent model of type 2 diabetes (T2D), icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with complete preservation of lean mass, ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
will present four peer-reviewed posters at the American Diabetes Association’s (ADA) 85th Scientific Sessions, which will take place June 20–23 in Chicago. These latest poster presentations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results